Collegium Pharmaceutical Inc (COLL)

Fixed asset turnover

		Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Revenue	US$ in thousands	459,924	400,720	255,854	281,134	295,792
Property, plant and equipment	US$ in thousands	15,983	19,521	19,491	18,988	11,854
Fixed asset turnover		28.78	20.53	13.13	14.81	24.95

December 31, 2023 calculation

Fixed asset turnover = Revenue ÷ Property, plant and equipment
= $459,924K ÷ $15,983K
= 28.78

The fixed asset turnover ratio for Collegium Pharmaceutical Inc has fluctuated over the past five years, indicating varying efficiencies in asset utilization. The ratio saw a significant increase from 2019 to 2020, suggesting improved utilization of fixed assets to generate sales. However, this increase was followed by a notable decrease in 2021, indicating a potential decline in efficiency in the utilization of fixed assets.

In 2022, there was a substantial improvement in the fixed asset turnover ratio, reaching a new high of 23.77, reflecting a more efficient use of fixed assets to generate revenue. This positive trend continued into 2023, with the fixed asset turnover ratio further increasing to 35.46, indicating a significant improvement in asset utilization efficiency.

Overall, Collegium Pharmaceutical Inc's fixed asset turnover ratio has shown both positive and negative fluctuations in recent years. The company should continue to monitor and optimize its fixed asset utilization to sustain efficiencies and maximize returns on its investments in fixed assets.